L-Dopa for Parkinson's Disease - A Bittersweet Pill

European Journal of Neuroscience - United Kingdom
doi 10.1111/ejn.14119
Full Text
Abstract

Available in full text

Categories
Neuroscience
Date
Authors
Publisher

Wiley

Related search

Selegiline (L-Deprenyl) and L-Dopa Treatment of Parkinson's Disease: A Double-Blind Trial.

Internal Medicine
Internal MedicineMedicine
1994English

Potential Mechanisms Underlying Anxiety and Depression in Parkinson's Disease: Consequences of L-Dopa Treatment

Neuroscience and Biobehavioral Reviews
Physiological PsychologyNeuropsychologyBehavioral NeuroscienceCognitive Neuroscience
2011English

The Role of GRK6 in Animal Models of Parkinson's Disease and L-Dopa Treatment

Scientific Reports
Multidisciplinary
2012English

Noradrenaline Neuron Degeneration Contributes to Motor Impairments and Development of L-Dopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease

Experimental Neurology
Developmental NeuroscienceNeurology
2014English

Differential Involvement of D1 and D2 Dopamine Receptors in L-Dopa-Induced Angiogenic Activity in a Rat Model of Parkinson's Disease

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2009English

Controlled Striatal DOPA Production From a Gene Delivery System in a Rodent Model of Parkinson's Disease

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Imaging Mass Spectrometry Reveals Elevated Nigral Levels of Dynorphin Neuropeptides in L-Dopa-Induced Dyskinesia in Rat Model of Parkinson's Disease

PLoS ONE
Multidisciplinary
2011English

Adjuvants to L-Dopa for Parkinsonism.

BMJ
1970English

In Silico Screening of Potent Natural Inhibitor Compounds Against Human DOPA Decarboxylase for Management of Parkinson's Disease

Canadian Journal of Biotechnology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy